Related Experiment Video
Updated: Dec 18, 2025
22:10
Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit
Published on: June 28, 2013
13.6K
Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach
Ahmad Abu Turab Naqvi1, Kisa Fatima2, Taj Mohammad1
1Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, Jamia Nagar, New Delhi 110025, India.
Summary
Minimal genomic variation in SARS-CoV-2 causes significant protein structure changes, rendering existing drugs ineffective against this novel coronavirus. Further research into SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) pathogenesis and targeted therapies is crucial.
Area of Science:
- Virology
- Genomics
- Drug Discovery
Background:
- The emergence of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) presents a global health crisis.
- Existing treatments for SARS-CoV and MERS-CoV are ineffective against SARS-CoV-2.
- Understanding SARS-CoV-2's unique characteristics is vital for effective therapeutic strategies.
Purpose of the Study:
- To analyze the genomic, proteomic, and pathogenic features of SARS-CoV-2.
- To compare SARS-CoV-2 with SARS-CoV and MERS-CoV at the genomic and protein levels.
- To explore structure-guided therapeutic approaches for SARS-CoV-2 infection.
Main Methods:
- Comparative genomic sequence analysis of SARS-CoV-2, SARS-CoV, and MERS-CoV.
- Analysis of mutations, genetic diversity, and pathogenicity in SARS-CoV-2.
- Structural analysis of potential drug target proteins.
- Cytokine profiling and inflammatory signaling pathway analysis.
Main Results:
- SARS-CoV-2 exhibits minimal genomic variation compared to related coronaviruses.
- Despite minor genomic differences, significant structural changes in target proteins were observed.
- Distinct cytokine profiles and inflammatory signaling pathways characterize SARS-CoV-2 infection.
- Existing drugs effective against SARS-CoV and MERS-CoV show limited efficacy against SARS-CoV-2.
Conclusions:
- Minor genomic alterations in SARS-CoV-2 can lead to substantial protein structural changes, impacting drug efficacy.
- Novel therapeutic strategies targeting SARS-CoV-2's unique molecular and pathogenic mechanisms are required.
- Further research into structure-function relationships and pathogenesis is essential for developing effective treatments.
Related Concept Videos
01:26Size and Structure of Viral Genomes
537
Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
537
02:02Genomics
39.4K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
39.4K
02:54Evolutionary Relationships through Genome Comparisons
6.7K
Genome comparison is one of the excellent ways to interpret the evolutionary relationships between organisms. The basic principle of genome comparison is that if two species share a common feature, it is likely encoded by the DNA sequence conserved between both species. The advent of genome sequencing technologies in the late 20th century enabled scientists to understand the concept of conservation of domains between species and helped them to deduce evolutionary relationships across diverse...
6.7K
01:05Single Nucleotide Polymorphisms-SNPs
17.7K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.7K
00:36Viral Mutations
39.4K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
39.4K
02:50Conjugated Proteins
25.6K
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
25.6K